Colin Odowd

Vice President of Medicinal Chemistry @Almac Group

Belfast, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2023 — Present

Vice President of Medicinal Chemistry @Almac Group

View department →

Belfast, GB

EDUCATION

1992 — 1996

The University of Edinburgh

BSc (Hons), Chemistry

1996 — 2000

Queen's University Belfast

PhD, Organic Chemistry

SKILLS

Pharmaceutical IndustryLc-MsScifinderFragment Based Drug DiscoveryBiotechnologyOrganometallic ChemistryMolecular ModelingComputational BiologyOncologyDrug DesignDrug DevelopmentChemistryDrug DiscoveryOrganic SynthesisComputational ChemistryCROR&DOrganic ChemistryHit to LeadSynthetic Organic ChemistryNmrPharmaceutical ResearchMedicinal ChemistryHeterocyclic ChemistryAdme

ABOUT COLIN ODOWD

I\'m a passionate, dynamic and driven medicinal chemistry leader with more than 20 years experience driving innovation and guiding successful drug discovery programs towards value inflection. My experience and skillset includes the following- Hit-finding/validation (FBLD,(v)HTS, DEL)- Hit-to-lead/Lead optimization (LO)/Lead-to-candidate nomination/IND-enabling studies- Platform building (target-class focused, chemoproteomics)- Synthetic/Medicinal Chemistry, CADD, QSAR modeling- Induced proximity: building capabilities/programs vs. next gen protein degradation targets- ADMET/DMPK, Pharmacology, Toxicology- Collaborative drug discovery (Pharma, Biotech, CROs)- Project/Portfolio/IP ManagementMy current role involves leading the medicinal chemistry, in silico and ADMET groups within Almac Discovery - I\'m part of the senior leadership team tasked with forging the strategic path of the company.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Colin Odowd — Vice President of Medicinal Chemistry at Almac Group in Belfast, GB | Unifers